Cencora (NYSE:COR) CEO Robert Mauch Sells 5,096 Shares

Cencora, Inc. (NYSE:COR) CEO Robert Mauch sold 5,096 shares of the company’s stock in a transaction dated Tuesday, November 18th. The shares were sold at an average price of $366.64, for a total value of $1,868,397.44. Following the sale, the chief executive officer owned 65,746 shares in the company, valued at approximately $24,105,113.44. The trade was a 7.19% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Cencora Price Performance

Shares of COR opened at $360.79 on Thursday. The firm has a market cap of $69.95 billion, a PE ratio of 37.12, a price-to-earnings-growth ratio of 1.56 and a beta of 0.63. Cencora, Inc. has a 52-week low of $223.92 and a 52-week high of $369.00. The business’s 50 day moving average price is $325.26 and its two-hundred day moving average price is $303.65. The company has a debt-to-equity ratio of 3.64, a quick ratio of 0.53 and a current ratio of 0.90.

Cencora (NYSE:COR) last announced its quarterly earnings data on Wednesday, November 5th. The company reported $3.84 EPS for the quarter, topping the consensus estimate of $3.79 by $0.05. Cencora had a net margin of 0.60% and a return on equity of 267.36%. The company had revenue of $83.73 billion during the quarter, compared to the consensus estimate of $83.36 billion. During the same quarter last year, the firm posted $3.34 EPS. The company’s quarterly revenue was up 5.9% on a year-over-year basis. Cencora has set its FY 2026 guidance at 17.450-17.75 EPS. On average, equities analysts anticipate that Cencora, Inc. will post 15.37 EPS for the current year.

Cencora Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 1st. Stockholders of record on Friday, November 14th will be given a dividend of $0.60 per share. This is a boost from Cencora’s previous quarterly dividend of $0.55. The ex-dividend date of this dividend is Friday, November 14th. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.7%. Cencora’s payout ratio is currently 30.19%.

Analyst Upgrades and Downgrades

A number of analysts recently commented on COR shares. TD Cowen boosted their target price on Cencora from $350.00 to $400.00 and gave the company a “buy” rating in a research report on Monday, November 10th. Evercore ISI set a $400.00 target price on shares of Cencora and gave the stock an “outperform” rating in a research report on Thursday, November 6th. Weiss Ratings restated a “buy (b-)” rating on shares of Cencora in a report on Thursday, October 30th. Mizuho raised their price target on shares of Cencora from $340.00 to $380.00 and gave the company an “outperform” rating in a research report on Thursday, November 6th. Finally, JPMorgan Chase & Co. boosted their price objective on Cencora from $344.00 to $417.00 and gave the stock an “overweight” rating in a report on Tuesday, November 11th. Nine analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $371.09.

Hedge Funds Weigh In On Cencora

A number of hedge funds and other institutional investors have recently modified their holdings of the business. Kingsview Wealth Management LLC increased its position in shares of Cencora by 21.1% during the 1st quarter. Kingsview Wealth Management LLC now owns 2,620 shares of the company’s stock valued at $728,000 after purchasing an additional 457 shares during the last quarter. Private Advisor Group LLC lifted its stake in Cencora by 9.2% in the first quarter. Private Advisor Group LLC now owns 6,796 shares of the company’s stock valued at $1,890,000 after purchasing an additional 572 shares during the last quarter. Kestra Private Wealth Services LLC grew its holdings in Cencora by 10.9% during the first quarter. Kestra Private Wealth Services LLC now owns 10,750 shares of the company’s stock valued at $2,989,000 after purchasing an additional 1,058 shares during the period. J.W. Cole Advisors Inc. grew its holdings in Cencora by 49.3% during the first quarter. J.W. Cole Advisors Inc. now owns 6,018 shares of the company’s stock valued at $1,674,000 after purchasing an additional 1,987 shares during the period. Finally, Obermeyer Wealth Partners increased its position in Cencora by 1.3% in the first quarter. Obermeyer Wealth Partners now owns 2,724 shares of the company’s stock worth $758,000 after buying an additional 36 shares during the last quarter. Hedge funds and other institutional investors own 97.52% of the company’s stock.

Cencora Company Profile

Cencora, Inc sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers.